Article
New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex.
The Journal of pathology - 1 Jan 2017
Lam Hilaire C, Nijmeh Julie, Henske Elizabeth P
Abstract excerpt
In just the past 5 years, dramatic changes have occurred in the clinical management of tuberous sclerosis complex (TSC). Detailed knowledge about the role of the TSC proteins in regulating the activity of the mammalian target of rapamycin complex 1 (mTORC1) underlies this paradigm-shifting progress. Advances continue to be made in understanding the genetic pathogenesis of the different tumours that occur in TSC,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
